We are live on
!
Find out more
CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$203M
1-Year Est. Return
17.67%
This Fund
S&P 500
This Quarter
Est. Return
+0.77%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$568M
AUM Growth
-$9.41M
(-1.6%)
Cap. Flow
+$1.58M
Cap. Flow
% of AUM
0.28%
Top 10 Holdings %
Top 10 Hldgs %
8.56%
Holding
680
New
121
Increased
206
Reduced
110
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regions Financial
RF
|
+$2.35M |
| 2 |
EPAM Systems
EPAM
|
+$2.11M |
| 3 |
MetLife
MET
|
+$2.08M |
| 4 |
Global Payments
GPN
|
+$2.03M |
| 5 |
Caesars Entertainment
CZR
|
+$2.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Diamondback Energy
FANG
|
+$3.57M |
| 2 |
KeyCorp
KEY
|
+$2.81M |
| 3 |
Truist Financial
TFC
|
+$2.6M |
| 4 |
Travelers Companies
TRV
|
+$2.57M |
| 5 |
Cognizant
CTSH
|
+$2.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.54% |
| 2 | Technology | 15.74% |
| 3 | Healthcare | 14.42% |
| 4 | Industrials | 12.89% |
| 5 | Energy | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Shattuck Labs
STTK
$682M
| $147K | 0.03% |
50,002
+3,075
| +7% | +$10.9K |
|
527
Alector
ALEC
$189M
| $147K | 0.03% |
23,691
+1,013
| +4% | +$8.24K |
|
528
Cartesian Therapeutics
RNAC
$265M
| $140K | 0.02% |
3,362
| – | – |
|
529
Nkarta
NKTX
$176M
| $139K | 0.02% |
39,196
+17,211
| +78% | +$81.6K |
|
|
IMA
530
ImageneBio Inc
IMA
$64.9M
| $136K | 0.02% |
3,288
+833
| +34% | +$38.3K |
|
|
PSTX
531
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $126K | 0.02% |
41,008
-25,108
| -38% | -$150K |
|
532
Fulcrum Therapeutics
FULC
$286M
| $126K | 0.02% |
44,078
+9,192
| +26% | +$82.4K |
|
533
CytomX Therapeutics
CTMX
$750M
| $124K | 0.02% |
82,415
-65,939
| -44% | -$149K |
|
|
GBIO
534
DELISTED
Generation Bio
GBIO
| $123K | 0.02% |
2,867
+15
| +0.5% | +$725 |
|
|
TCRR
535
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $107K | 0.02% |
71,046
+3,011
| +4% | +$4.05K |
|
536
Precision BioSciences
DTIL
$206M
| $101K | 0.02% |
4,476
| – | – |
|
537
Passage Bio
PASG
$13.9M
| $97.2K | 0.02% |
5,074
+61
| +1% | +$1.65K |
|
538
Editas Medicine
EDIT
$432M
| $84.6K | 0.01% |
11,665
| – | – |
|
539
Q32 Bio
QTTB
$466M
| $83.6K | 0.01% |
4,507
| – | – |
|
|
SURF
540
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $79.1K | 0.01% |
113,219
+4,795
| +4% | +$3.88K |
|
541
Praxis Precision Medicines
PRAX
$10.2B
| $59.2K | 0.01% |
4,875
+10
| +0.2% | +$422 |
|
|
KRON
542
DELISTED
Kronos Bio
KRON
| $50.1K | 0.01% |
34,307
+5,030
| +17% | +$9.64K |
|
543
Nektar Therapeutics
NKTR
$2.53B
| $46.8K | 0.01% |
4,442
+149
| +3% | +$4.51K |
|
544
Taysha Gene Therapies
TSHA
$1.83B
| $44.2K | 0.01% |
55,359
| – | – |
|
545
Amalgamated Financial
AMAL
$1.48B
| – | – |
-20,548
| Closed | -$473K |
|
|
GOLD
546
Gold.com Inc
GOLD
$1.26B
| – | – |
-16,180
| Closed | -$562K |
|
547
Broadcom
AVGO
$2.01T
| – | – |
-33,640
| Closed | -$1.88M |
|
548
Avantor
AVTR
$9.29B
| – | – |
-29,176
| Closed | -$615K |
|
549
Avery Dennison
AVY
$13.5B
| – | – |
-10,161
| Closed | -$1.84M |
|
550
Banc of California
BANC
$3B
| – | – |
-27,977
| Closed | -$446K |
|
Similar funds
NWM
EECFX
PSB
HIA
NMG
EECFX
BC
EFA
Cornercap Investment Counsel's Q1 2023 Portfolio in Review
As of Q1 2023, Cornercap Investment Counsel held 680 positions worth $568M, down 1.6% from $578M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Cornercap Investment Counsel's Q1 2023 filing shows 121 new, 206 increased, 110 reduced and 119 closed positions. Its largest new stake was Regions Financial: 108,036 shares worth $2.01M. The largest sale was Diamondback Energy, an estimated $3.57M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
- Cornercap Investment Counsel's largest Q1 2023 buy was Regions Financial: 108,036 shares worth $2.01M.
- Cornercap Investment Counsel added most to Cigna in Q1 2023, an estimated $1.93M increase.
- Cornercap Investment Counsel's biggest Q1 2023 reduction was Diamondback Energy, cutting an estimated $3.57M.
- Cornercap Investment Counsel fully exited KeyCorp in Q1 2023, selling an estimated $2.81M.
- Cornercap Investment Counsel's ten largest holdings make up 8.6% of its $568M portfolio in Q1 2023.
- Cornercap Investment Counsel opened 121 new positions and closed 119 in Q1 2023.
- Cornercap Investment Counsel's portfolio value fell 1.6% quarter-over-quarter to $568M.
Based on Cornercap Investment Counsel's 13F filing for Q1 2023, filed 11 May 2023.